Persistent luminescence nanoparticles for bioimaging

Advances in Intelligent and Soft Computing

Volumn 120, Issue , 2012, Pages 37-53

  Richard, Cyrille ^a   Maldiney, Thomas ^a,b,c,d   Le Masne De Chermont, Quentin ^a,b,c,d   Seguin, Johanne ^a,b,c,d   Wattier, Nicolas ^a,b,c   Courties, Gabriel ^a   Apparailly, Florence ^a   Bessodes, Michel ^e,f,g   Scherman, Daniel ^e,f,g  

^a CNRS   (France)

^b Centre National de la Recherche Scientifique   (France)

^c FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^d PSL RESEARCH UNIVERSITY   (France)

^e INSERM   (France)

^f UNIV MONTPELLIER   (France)

^g LAPEYRONIE HOSPITAL   (France)

Author keywords

Biodistribution; Biomedical imaging; Inflammation; Nanoparticle; Persistent luminescence; Silicate; Surface coating; Tumor targeting

Indexed keywords

BIODISTRIBUTIONS; BIOMEDICAL IMAGING; INFLAMMATION; PERSISTENT LUMINESCENCE; SURFACE COATING; TUMOR TARGETING;

FLUORESCENCE; MEDICAL IMAGING; NANOPARTICLES; OPTICAL IMAGE STORAGE; SILICATES; TISSUE;

LIGHT;

EID: 84856244941     PISSN: 18675662     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-25547-2_4     Document Type: Conference Paper

References (30)

1. [Brannon-Peppas et al. 2004] Brannon-Peppas, L., Blanchette, J.O.: Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56, 1649-1659 (2004) (Pubitemid 39177694)
2. [Brinker et al. 1990] Brinker, C.J., Scherer, G.W.: Sol-Gel Science: The physics and the chemistry of sol-gel processing (1990) (academic London)
3. [Byrne et al. 2008] Byrne, J.D., Betancourt, T., Brannon-Peppas, L.: Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 60, 1615-1626 (2008)
4. [Chen et al. 2005] Chen, W., Mahmood, U., Weissleder, R., Tung, C.: Arthritis Imaging Using a Near-Infrared Fluorescence Folate-Targeted Probe. Arthritis Res.Ther. 7, R310-317 (2005)
5. [Choi 2007] Choi, H.S.: Renal Clearance of Quantum Dots. Nat. Biotechnol. 25, 1165-1170 (2007)
6. [Choy et al. 2001] Choy, E.H., Panayi, G.S.: Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907-916 (2001) (Pubitemid 32224400)
7. [Courties et al. 2009] Courties, G., Presumey, J., Duroux-Richard, I., Jorgensen, C., Apparailly, F.: RNA interference-based gene therapy for successful treatment of rheumatoid arthritis. Expert Opin. Biol. Ther. 9, 535-538 (2009)
8. [Greenwald 2001] Greenwald, R.B.: PEG drug: an overview. J. Controlled Release 74, 159-171 (2001)
9. [Jiang et al. 2003] Jiang, L., Chang, C., Mao, D.: Luminescent properties of CaMgSi2O6 and Ca2MgSi2O7 phosphors activated by Eu2+, Dy3+ and Nd3+. J. Alloys Comp. 360, 193-197 (2003)
10. [Kamps et al. 1997] Kamps, J.A., Morselt, H.W.M., Swart, P.J., Meijer, D.K.F., Scherphof, G.L.: Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc. Natl. Acad. Sci. USA 94, 11681-11685 (1997) (Pubitemid 27451058)
11. [Krieger et al. 1994] Krieger, M., Herz, J.: Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein. Annu. Rev. Biochem. 63, 601-637 (1994)
12. [le Masne de Chermont et al. 2007] Le Masne de Chermont, Q., Chanac, C., Seguin, J., Pelle, F., Matrejean, S., Jolivet, J.P., Gourier, D., Bessodes, M., Scherman, D.: Nanoprobes with Near-Infrared Persistent Luminescence for In Vivo Imaging. Proc. Natl. Acad. Sci. USA 104, 9266-9271 (2007) (Pubitemid 47193021)
13. [le Masne de Chermont et al. 2009] le Masne de Chermont, Q., Richard, C., Seguin, J., Chanac, C., Bessodes, M., Scherman, D.: Silicates doped with luminescent ions: useful tools for optical imaging applications. In: Proc of SPIE, vol. 7189, 71890B/1-71890B (2009)
14. [Li et al. 2004] Li, Z.F., Ruckenstein, E.: Water-soluble poly(acrylic acid) grafted luminescent silicon nanoparticles and their use as fluorescent biological staining labels. Nano. Lett. 4, 1463-1467 (2004) (Pubitemid 39186330)
15. [Longmire et al. 2008] Longmire, M., Choyke, P.L., Kobayashi, H.: Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3, 703-717 (2008)
16. [Loomis et al. 2011] Loomis, K., McNeeley, K., Bellamkonda, R.V.: Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications. Soft Matter 7, 839-856 (2011)
17. [Maeda et al. 2000] Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K.: Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release 65, 271-284 (2000) (Pubitemid 30122932)
18. [Maldiney et al. 2011] Maldiney, T., Richard, C., Seguin, J., Wattier, N., Bessodes, M., Scherman, D.: Effect of core diameter, surface coating and PEG chain length on the biodistribution of persistent luminescent nanoparticles in mice. ACS Nano 5, 854-862 (2011)
19. [Medintz et al. 2005] Medintz, I.L., Uyeda, H.T., Goldman, E.R., Mattoussi, H.: Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mate 4, 435-446 (2005) (Pubitemid 40774047)
20. [Minchin et al. 2010] Minchin, R.F., Martin, D.J.: Nanoparticles for molecular imaging - an overview. Endocrinology 151, 474-481 (2010)
21. [Moghimi et al. 2001] Moghimi, S.M., Hunter, C., Murray, J.C.: Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 53, 283-318 (2001) (Pubitemid 32476118)
22. [Park et al. 2009] Park, J.H., Gu, L., von Maltzahn, G., Ruoslahti, E., Bhatia, S.N., Sailor, M.J.: Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater 8, 331-336 (2009)
23. [Resch-Genger et al. 2008] Resch-Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R., Nann, T.: Quantum dots versus organic dyes as fluorescent labels. Nat. Methods 5, 763-775 (2008)
24. [Richard et al 2008] Richard, C., le Masne de Chermont, Q., Scherman, D.: Nanoparticles for imaging and tumor gene delivery. Tumori 94, 264-270 (2008) (Pubitemid 351838834)
25. [Salonen et al. 2007] Salonen, J., Kaukonen, A.M., Hirvonen, J., Lehto, V.P.: Mesoporous silicon in drug delivery applications. J. Pharm. Sci. 97, 632-653 (2007)
26. [Smith et al. 2008] Smith, A.M., Duan, H., Mohs, A.M., Nie, S.: Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug. Deliver Rev. 60, 1226-1240 (2008)
27. [Song et al. 1998] Song, Y.K., Liu, F.: Liu Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA. Gene. Ther. 5, 1531-1537 (1998) (Pubitemid 28517380)
28. [Tak et al. 1996] Tak, P.P., Taylor, P.C., Breedveld, F.C., Smeets, T.J.M., Daha, M.R., Kluin, P.M., Meinders, A.E., Maini, R.N.: Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 39, 1077-1081 (1996) (Pubitemid 26240218)
29. [Wang et al. 2003] Wang, X.J., Jia, D., Yen, W.M.: Mn2+ activated green, yellow, and red long persistent phosphors. J. Lumin 103, 34-37 (2003)
30. [Weissleder et al. 2008] Weissleder, R., Pittet, M.J.: Imaging in the era of molecular oncology. Nature 452, 580-589 (2008) (Pubitemid 351483372)